ERNA vs K · P/E 0.0, rev $582.0K vs P/E 23, $29.03B cap
Eterna Therapeutics Inc (ERNA) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Kellanova (K) is a packaged foods company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
K does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the ERNA and K stock pages for the full models.
Not investment advice.